GLYBURIDE AND METFORMIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glyburide And Metformin Hydrochloride, and when can generic versions of Glyburide And Metformin Hydrochloride launch?
Glyburide And Metformin Hydrochloride is a drug marketed by Actavis Elizabeth, Aurobindo Pharma, Heritage, Impax Labs Inc, Teva, and Zydus Pharms. and is included in seven NDAs.
The generic ingredient in GLYBURIDE AND METFORMIN HYDROCHLORIDE is glyburide; metformin hydrochloride. There are twenty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the glyburide; metformin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glyburide And Metformin Hydrochloride
A generic version of GLYBURIDE AND METFORMIN HYDROCHLORIDE was approved as glyburide; metformin hydrochloride by IMPAX LABS INC on February 18th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GLYBURIDE AND METFORMIN HYDROCHLORIDE?
- What are the global sales for GLYBURIDE AND METFORMIN HYDROCHLORIDE?
- What is Average Wholesale Price for GLYBURIDE AND METFORMIN HYDROCHLORIDE?
Summary for GLYBURIDE AND METFORMIN HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 7 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 25 |
Patent Applications: | 23 |
DailyMed Link: | GLYBURIDE AND METFORMIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for GLYBURIDE AND METFORMIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The University of Texas Health Science Center, Houston | Phase 4 |
University of Illinois at Chicago | Phase 3 |
Texas Tech University Health Sciences Center | Phase 3 |
See all GLYBURIDE AND METFORMIN HYDROCHLORIDE clinical trials
Pharmacology for GLYBURIDE AND METFORMIN HYDROCHLORIDE
Drug Class | Biguanide Sulfonylurea |